53938-24-2

Usage

Uses

Used in Pharmaceutical Industry:
1-bromo-4,5-dimethyl-2-nitrobenzene is used as a synthetic intermediate for the production of pharmaceuticals. Its unique structure allows for the creation of a variety of medicinal compounds, contributing to the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical sector, 1-bromo-4,5-dimethyl-2-nitrobenzene is employed as a precursor in the synthesis of agrochemicals. Its reactivity and functional groups make it suitable for the development of compounds used in crop protection and pest control.
Used in Dye Industry:
1-bromo-4,5-dimethyl-2-nitrobenzene is used as a starting material in the production of dyes. Its chemical properties enable the synthesis of a range of dyes with specific color characteristics, used in various applications such as textiles, plastics, and printing inks.
As a Hazardous Chemical:
1-bromo-4,5-dimethyl-2-nitrobenzene is considered a hazardous chemical due to its reactive nature and potential health effects. It requires careful handling and storage to ensure safety in industrial applications and to minimize environmental impact.

Upstream product

• 6972-71-0 4,5-dimethyl-2-nitrobenzenamine 
• 583-71-1 4-bromo-o-xylene 
• 99-51-4 4-nitro-o-xylene 

Downstream Products

• 81614-97-3 4,5-Dimethyl-2-phenoxy-nitrobenzol 
• 872087-53-1 (S)-N-[4,5-dimethyl-2-nitrophenyl]-S-methyl-S-phenylsulfoximine 
• 74716-85-1 5-(4,5-dimethyl-2-nitrophenylamino)pentan-1-ol 
• 1207983-97-8 tert-butyl 4-(2-[(4,5-dimethyl-2-nitrophenyl)amino]ethoxy)butanoate 
• 1338684-72-2 tert-butyl (1-((4,5-dimethyl-2-nitrophenyl)amino)-3-phenylpropan-2-yl)carbamate 
• 1338684-57-3 N-[3-(4-chlorophenyl)propyl]-4,5-dimethyl-2-nitroaniline 
• 1242840-80-7 5-(4,5-dimethyl-2-nitro-phenyl)-furan-2-carbaldehyde 
• 1338685-23-6 N-[2-(benzyloxy)-3-phenylpropyl]-4,5-dimethyl-2-nitroaniline 
• 1338684-81-3 N-(2-isopropoxy-3-phenylpropyl)-4,5-dimethyl-2-nitroaniline 
• 1338685-20-3 10-[2-(benzyloxy)-3-phenylpropyl]-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338685-24-7 N-[2-(benzyloxy)-3-phenylpropyl]-4,5-dimethylbenzene-1,2-diamine 
• 1338685-11-2 10-(2-(benzylamino)-3-phenylpropyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-80-2 10-(2-isopropoxy-3-phenylpropyl)-7,8-dimethylbenzo[g]pteridine-2,4(3H,10H)-dione 
• 1338684-83-5 N-(2-isopropoxy-3-phenylpropyl)-4,5-dimethylbenzene-1,2-diamine 

Relevant academic research and scientific papers

Histone acetyltransferase P300 small molecule inhibitor and medicinal composition and application thereof

The compound capable of inhibiting histone acetyltransferase, has a significant inhibition effect p300 in inhibiting the activity, of the histone acetyltransferase, or a pharmaceutically acceptable salt (I) of; has a significant inhibitory effect on tumor cells such as the primary, representative small molecule inhibitor p300 to prostate cancer cells, malignant blood tumor cells p300 breast cancer cells, and has an effect of inhibiting the toxicity C646, of the compound by overcoming the defects, of the original, small molecule inhibitor, existing in the present invention. C646 p300. The compounds of the formula C646; are shown in, Table (I). The invention belongs to, the field of pharmaceutical chemistry.

FLAVIN DERIVATIVES

The present invention relates novel flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives.

Methods and Compositions for Modulating P300/CBP Activity

The present invention relates to a method for identifying compounds that modulate the activity of p300/CBP. Compounds of the invention are identified by designing or screening for a compound which binds to at least one amino acid residue of the newly identified lysine-CoA inhibitor binding site, L1 loop, electronegative pocket, or electronegative groove of the HAT domain of p300/CBP and testing the compound for its ability to modulate the activity of p300/CBP. Compositions and methods for preventing or treating diseases or disorders associated with p300/CBP are also provided as is a method for producing a semi-synthetic HAT domain.

Highly modular synthesis of C1-symmetric aminosulfoximines and their use as ligands in copper-catalyzed asymmetric Mukaiyama-Aldol reactions

The development of C1-symmetric aminosulfoximines, their highly modular synthesis, and their application in enantioselective copper-catalyzed Mukaiyama-type aldol reactions between pyruvates and enolsilanes is described. In this context, the in

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides 4,4-(disubstituted)piperidine derivatives represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM

The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.

Benzofuran derivatives and their pharmaceutical use

Benzofuran derivatives of the formula STR1 wherein V is hydrogen or acetyl, X is oxo or two hydrogen atoms, R1 and R2 each independently is hydrogen, fluorine, or chlorine, and --A--B-- is --O--CH2 -- or --CH2 -